{"id":"W2970632109","doi":"10.1182/blood.v130.suppl_1.3886.3886","title":"Investigating the Efficacy of Anti-CD200 Immunotherapy in MRD Low and Risk B Cell Precursor ALL","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Minimal residual disease; Antigen; Immunology; Population; CD19; Medicine; Immunotherapy; Cancer research; Immune system; Chimeric antigen receptor; Oncology; Internal medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003138471,0.0001708795,0.0003548045,0.0002349102,0.0001406116,0.0002973977,0.0001987676,0.0002554137,0.0007906684],"category_scores_gemma":[0.0001862826,0.00008443387,0.0001957766,0.0001205163,0.0001693996,0.0002169665,0.0001425463,0.0005899522,0.0001499241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001838568,"about_ca_system_score_gemma":0.0001311983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002370505,"about_ca_topic_score_gemma":0.000328656,"domain_scores_codex":[0.9998727,0.00003887651,0.00001077755,0.00002193552,0.00002811826,0.00002759069],"domain_scores_gemma":[0.9998815,0.00003711987,0.00001808655,0.00001615536,0.00001174275,0.00003523812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.009911802,0.003981267,0.01056214,0.0003912412,0.0001017285,0.0003871526,0.0001663103,0.001006932,0.9143655,0.0003000537,0.0004313675,0.05839447],"study_design_scores_gemma":[0.001833218,0.1299277,0.07419018,0.00006256797,0.0007552783,0.003602348,0.0003116467,0.005396132,0.765609,0.0004525114,0.01783487,0.00002467383],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973483,0.001606119,0.0002754336,0.00005725841,0.00001888114,0.00003937843,0.00003919402,0.00001692638,0.0005985056],"genre_scores_gemma":[0.9983215,0.0005336649,0.0004401772,0.00005014688,0.00002476907,0.00003684501,0.0001125996,0.000003881192,0.0004763594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007906684,"threshold_uncertainty_score":0.002645016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01792632301465033,"score_gpt":0.2901116358407277,"score_spread":0.2721853128260774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}